Publicacions de Pneumologia

Articles a publicacions mèdiques

Publicacions internacionals
Professions and working conditions associated with community-acquired pneumonia.
Almirall J, Serra-Prat M, Bolibar I, Palomera E, Roig J et al.
Arch Bronconeumol 2015; 51:627-631

Passive smoking at home as risk factor for community-acquired pneumonia in older adults.
Almirall J, Serra M, Bolibar I, Palomera E, Roig J et al (Study group of community-acquired pneumonia in Catalan contries –PACAP).
BMJ Open 2014; 4(6): e005133

Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.
Almirall J, Bolibar I, Serra M, Palomera E, Roig J et al.
PLoS ONE 2013; 8(9):e73271

Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy.
Rello J, Gattarello S, Souto J, Sole-Violan J, Valles J, Peredo R, Zaragoza R, Vidaur L, Parra A, Roig J.
Med Inten 2013; 37:320-6

Oral ribaroxaban for the treatment of symtopmatic pulmonary embolism.
Roig J - Einstein – PE Group.
New Eng J Med 2012; 366:1287-97

Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community – Acquired Pneumonia Organization (CAPO) International Cohort Study.
Arnold FW et al. Roig J (List of participants).
Respiratory Medicine 2010; 104:1736-43

Inhaled drugs as risk factors for community-acquired pneumonia.
Almirall J, Bolibar I, Serra M, Palomera E, Roig J, et al.
European Respiratory Journal 2010; 36:1080-1087

Screening for epidermal growth factor receptor mutations in lung cancer.
Roig J (List of participants).
New Eng J Med 2009; 361:958-67

Roflumilast in moderate–to-severe chronic obstructive lung disease treated with longacting bronchodilators: two randomised clinical trials.
Roig J (List of participants).
Lancet 2009; 374: 665-67

The pneumonia severity index and the CRB-65 in cancer patients with community-adquired pneumonia.
Roig J (List of participants).
Int J Tuberc Lung Dis 2009; 13:1550-56

Indacaterol, a novel once daily inhaled B2 adrenoreceptor agonist.
Roig J, Hernando R, Mora R.
Open Resp Med J, 2009; 3:27-30

Risk factors for multidrug-resistant pneumococcal pneumonia.
The Pneumococcal Pneumonia in Spain Study Group: Aspa J, Rajas O, Rodriguez de Castro F, Torres A, Blanquer J, Zalacain R, Vendrell M, Gallego M, Puzo C, Andreu F, Menendez R, Martinez E, Roig J et al.
Infect Dis Clin Practice 2008; 16:368-375

New evidence of risk factors for community-acquired pneumonia: a population-based study.
Almirall J, Bolibar I, Serra-Prat M, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Roig J and the Community-Acquired Pneumonia Group in Catalonia (PACAP).
Eur Resp J 2008; 31:1274-84

New developments in therapeutic agents for Legionnaires’ disease.
Roig J, Arnau JM, Vallano A, Rello J.
Anti-Infective Agents in Medicinal Chemistry, 2007, 6:228-242

Neglected respiratory toxicity caused by cancer therapy.
Domingo C, Roig J.
Open Respiratory Medicine Reviews, 2007; 1:1-6

What is new in Legionella management?
Roig J, Marqués J, Miralles JC, Canturri E.
Clinical Pulmonary Medicine 2007; 14:321-329

Implications of COPD in patients admitted to the intensive care unit by community acquired pneumonia.
Rello J, Rodriguez A, Torres A, Roig J, et al.
Eur Resp J 2006; 27: 1-7.

Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents.
Roig J, Casal J, Gispert P, Gea E.
Med Mal Infect 2006; 36:680-689

Using the pneumonia severity index to predict time to switch therapy in hospitalized patients with community-acquired pneumonia: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study.
Arnold FW, LaJoie AS, Marrie T, Rossi P, Blasi F, Luna C, Fernandez P, Porras J, Weiss K, Feldman C, Rodriguez E, Levy G, Arteta F, Roig J, Rello J, Ramirez J.
Int J Tuberc Lung Dis 2006; 10:739-43

Pulmonary toxicity caused by cytotoxic drugs.
Roig J, Gea E, Domingo C.
Clin Pulm Med 2006; 13:53-62

Fluoroquinolones versus macrolides in the treatment of Legionnaires’ disease.
Sabria M, Pedro-Botet ML, Gómez J, Roig J, Vilaseca B, Sopena N, Baños V.
Chest 2005; 128:1401-1405

Legionnaires’ disease and the updated IDSA guidelines for community-acuired pneumonia.
Yu VL, Ramirez J, Roig J, Sabria M.
Clin Infect Dis 2004; 39: 1734-1736

Acute and long-term hemodynamic response to home oxygen therapy: nasal prongs versus oxygen saving devices.
Domingo C, Klamburg J, Roig J, et al.
Journal of Applied Research 2004; 4:149-163

Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
Pneumococcal Pneumonia in Spain Study Group (Roig J, member).
Clin Infect Dis 2004; 38:787-798

Publicacions nacionals
Tratamiento antibiótico de la NAC causada por agentes atípicos.
Roig J, Casal J, Gispert P, et al.
SIMID Review On, 2007.

Repercusión del humo de tabaco en la salud (II).
Roig J, Hernando R.
Medicina General, vol 102, Diciembre 2007, 809-811

Repercusión del humo de tabaco en la salud (I)
Roig J, Hernando R.
Medicina General, vol 101, Noviembre 2007, 739-741

Recomendaciones para el diagnóstico y tratamiento de la Neumonía Adquirida en la Comunidad, Sociedad Española de Neumología y Cirugía Torácica (SEPAR).
Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Área de Tuberculosis e Infecciones Respiratorias (TIR) de la SEPAR. . Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, Bravo C, Celis R, de Gracia X, Dorca J, Gallardo J, Gallego M, Menéndez R, L. Molinos L, Paredes C, Rajas O, Rello J, Rodríguez de Castro F, Roig J, Sánchez- Gascón F, Torres A, Zalacain R.
Arch Bronconeumol 2005; 41:272-289.

Está justificada la inclusión de levofloxacino en el tratamiento antibiótico empírico de las exacerbaciones de la EPOC leve, en pacientes sin comorbilidad y edad < 65 años?
Roig J, Martínez J, Casal J.
Arch Bronconeumol 2002; 38:547-548

Capítols de llibres

Llibres internacionals
Legionnaires’ Disease.
Roig J, Sabria M, Castella X.
Chapter 37 of “Infectious Diseases in Critical Care”. Rello J & Kollef M editors. 2007, Springer Verlag Publishers, Berlin, 404-412

Legionella and the Prevention of Legionellosis.
Roig J (Contributor)
World Health Organization (WHO), 2007, WHO Library, ISBN 92 4 156297 8 (NLM classification: WC 200)

Legionellosis.
Roig J, Rello J.
Section IV of “Conn’s Current Therapy”, Rakel R & Bope E editors; 59th edition, Saunders Elsevier Publisher, Philadelpia, PA 2007

Microbial etiology and resistance.
Rello J, Roig J.
Respiratory Infections. Chapter 40. Torres, Ewig, Mandell & Woodhead editors. 2006

Risk factors for Ventilator-Associated Pneumonia.
Craven D, Roig J, de la Rosa F.
Chapter 6 of "Severe Pneumonia. Lung Biology in Health and Disease Series (Volume 206)". Taylor & Francis Inc, Marcel Dekker Books, 2005, 109-136, 1st edition, New York

Spectrum of Pseudomonas aeruginosas Disease.
Roig J, Sabria M.
Chapter 2 of “Severe Pseudomonas aeruginosas” infections. Perspectives on Critical Care Infectious Diseases. Hauser A & Rello J editors. Boston; Kluwer Academic Publishers, 2003 , 18-36.

Infection Section
Roig J (Editor)
“Year Book in Pulmonary Medicine”, Harding FM & Morera J, editors. Clinical Publishing Service, England, 2002 ( Review and comments on 50 selected articles published in 2001)

Approach to severe legionellosis.
Roig J, Domingo C.
Chapter 4 of “Severe community-acquired pneumonia”. Perspectives on Critical Care Infectious Diseases. Rello J & Leeper KV editors. Boston; Kluwer Academic Publishers, 2001; 41-56
Llibres nacionals
Causas infrecuentes de tos.
Roig J.
En el libro “Informe I Symposium Internacional: La Tos en la práctica clínica – Barcelona 2015”. Mederic Ediciones 2015; pp 23-24

Carcinoma broncogénico: factores pronósticos y evolución.
Roig J, Hernando R.
Capítulo 57: pp 475-483. En: Alvarez-Sala Walther JL et al ed. Neumologia Clínica, Elsevier Ed, Barcelona, 2010; ISBN: 978-84-8086-2981-1

Pautas actuales de tratamiento multimodal en cáncer de pulmón no microcítico.
Roig J, Recuero R, Gispert P.
Capítulo 3, Fascículo 1: pp 33-42. En: Formación Médica Continuada (FMC) de la SEPAR (Sociedad Española de Neumología y Cirugia Torácica) y SEAFORMEC (Sistema Español de Acreditación de la Formación Médica Continuada. Sanitaria 2000 Editorial. 2008

Hemoptisis masiva.
Roca M, Pobo A, Roig J.
Capítulo 26 del libro “Medicina Intensiva Respiratoria. Principios y práctica”. De Mendoza et al editores. Silva Editorial, 313-326, 2008

EPOC y Cáncer de pulmón.
Roig J, Canturri E.
Libro de Ponencias del XX Symposium Internacional sobre EPOC. Capítulo 17, Mayo ediciones, Barcelona, 2007, pp 53-57.

Neumonía por Legionella.
Roig J, Casal J, Domingo C.
Neumonía Extrahospitalaria. Morera J, ed. Cap 4, pp 37-53.Temis Pharma ed, Barcelona, 2000.

Neumonía por Legionella.
Domingo C, Roig J.
Infecciones graves. Implicaciones terapéuticas de la neumonía extrahospitalaria grave. Rello J, Gallego M, eds. Edika Med Edición Médica, Barcelona, 1999

Neumonía nosocomial por Legionella.
Domingo C, Roig J.
Infecciones graves. Implicaciones terapéuticas de la neumonía nosocomial grave. Rello J, Gallego M, eds. Edika Med Edición Médica, Barcelona, 1999

Asma i reflux gastroesofàgic.
Roig J.
Asma bronquial. Marín A. ed. Acadèmia de Ciències Mèdiques de Catalunya i de Balears. 1998.